Home › Ovarian Epithelial Carcinoma › Texas › Houston
Ovarian Epithelial Carcinoma clinical trials in Houston, TX
7 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RecruitingPhase 1
- Site 0103, Houston
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Houston Methodist Hospital /ID# 274568, Houston
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
RecruitingPhase 3
- Research Site, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RecruitingPhase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Ovarian Epithelial Carcinoma trials in other cities
- New York City, NY10 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Cleveland, OH7 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Salt Lake City, UT6 studies
- Edison, NJ5 studies
- Los Angeles, CA5 studies
- Minneapolis, MN5 studies
- Portland, OR5 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.